Discovery of TNI-97 as a Highly Selective, Orally Bioavailable HDAC6 Inhibitor for the Treatment of Triple-Negative Breast Cancer.

paclitaxel - Generic mfg.

rocilinostat (ACY-1215) - Regenacy

http://www.ncbi.nlm.nih.gov/pubmed/40607730

Bo Li; Changjun Bai; Dan Liu; Han Qin; Jiachen Wen; Jinyu Sha; Leyan Wei; Linxiang Zhao; Meidi Luo; Pinghua Sun; Qihao Xu; Rongxian Guo; Shanshan Shao; Siyuan Wang; Wenchao Zhang; Xintian Yu; Yifei Cui

Jul 3, 2025